Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
7.715 USD | +1.65% | -5.24% | -33.65% |
Chart calendar Ironwood Pharmaceuticals, Inc.
Upcoming events on Ironwood Pharmaceuticals, Inc.
Past events on Ironwood Pharmaceuticals, Inc.
2024-03-03 02:00 pm | American Society for Parenteral and Enteral Nutrition Science and Practice Conference |
2024-03-03 12:45 pm | American Society for Parenteral and Enteral Nutrition Science and Practice Conference - Long-Acting |
2024-03-03 12:45 pm | American Society for Parenteral and Enteral Nutrition Science and Practice Conference - Dr. Dejan Mi |
2024-03-03 12:45 pm | American Society for Parenteral and Enteral Nutrition Science and Practice Conference - Short Bowel |
2024-03-03 12:45 pm | American Society for Parenteral and Enteral Nutrition Science and Practice Conference - Pharmacokine |
2024-02-29 08:00 am | Apraglutide Phase 3 Clinical Trial Results Call |
2024-02-15 08:30 am | Q4 2023 Earnings Call |
2024-02-15 07:00 am | Q4 2023 Earnings Release |
2024-01-10 02:15 pm | JPMorgan Healthcare Conference |
2023-11-29 09:00 am | Piper Sandler Healthcare Conference |
2023-11-09 08:30 am | Q3 2023 Earnings Call |
2023-11-09 07:00 am | Q3 2023 Earnings Release |
2023-10-07 03:30 pm | North American Society for Pediatric Gastroenterology, Hepatology & Nutrition Meeting - Presentation |
2023-10-07 03:30 pm | North American Society for Pediatric Gastroenterology, Hepatology & Nutrition Meeting - Presentation |
2023-10-06 03:30 pm | North American Society for Pediatric Gastroenterology, Hepatology & Nutrition Meeting - Presentation |
2023-08-08 08:30 am | Q2 2023 Earnings Call |
2023-08-08 07:00 am | Q2 2023 Earnings Release |
2023-06-19 | Annual General Meeting |
2023-05-22 08:30 am | Acquisition of VectivBio Holding AG by Ironwood Pharmaceuticals, Inc Call |
2023-05-16 01:30 pm | JMP Securities Life Sciences Conference - Fireside Chat |
Past dividends on Ironwood Pharmaceuticals, Inc.
2019-04-01 | 0 |
Annual results
Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 428 416 3.1% | 390 381 2.36% | 414 407 1.57% | 411 411 -0.2% | 443 443 -0.03% | 448 |
EBITDA Million USD | Released Forecast Spread | 148 105 40.85% | 161 146 10.23% | 234 246 -5.04% | 252 250 0.67% | -885 192 -560.24% | 157 |
EBIT Million USD | Released Forecast Spread | 120 97,8 22.87% | 143 149 -3.82% | 232 241 -3.5% | 250 249 0.67% | -945 -384 -146.32% | 153 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 21,5 16,6 29.43% | 109 114 -4.51% | 201 208 -3.31% | 252 247 2.33% | -948 -951 0.28% | 129 |
Net income Million USD | Released Forecast Spread | 21,5 17,0 26.81% | 106 112 -5.03% | 528 540 -2.1% | 175 174 0.75% | -1 002 -967 -3.61% | 106 |
EPS USD | Released Forecast Spread | 0,14 0,13 6.14% | 0,66 0,68 -2.58% | 3,21 3,26 -1.4% | 0,96 0,94 1.77% | -6,45 -6,38 -1.1% | 0,78 |
Announcement Date | 13/02/20 | 17/02/21 | 17/02/22 | 16/02/23 | 15/02/24 | - |
Quarterly results
Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 117 110 6.31% | 97,5 96,6 0.94% | 97,2 104 -6.07% | 109 110 -1.6% | 107 108 -0.95% | 104 101 3.44% | 107 104 3.54% | 114 113 0.82% | 118 117 0.13% | 106 | 112 | 115 | 114 | 110 |
EBITDA Million USD | Released Forecast Spread | 57,0 | 56,0 67,5 -17.01% | 68,8 67,8 1.59% | 68,7 68,0 1.03% | 60,4 59,0 2.34% | -1 034 60,4 -1812.39% | 49,1 23,0 113.06% | 39,9 45,7 -12.7% | 32,2 | 37,3 | 40,2 | 39,0 | 37,0 | |
EBIT Million USD | Released Forecast Spread | 56,6 63,9 -11.44% | 57,8 51,0 13.48% | 55,7 61,9 -10.04% | 68,5 67,6 1.36% | 68,4 66,6 2.61% | 60,1 59,4 1.23% | 20,3 59,4 -65.79% | 40,0 34,8 14.93% | 37,6 43,7 -13.89% | 31,5 | 41,6 | 40,6 | 41,8 | 36,9 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 46,3 | 56,5 46,5 21.56% | 53,8 57,7 -6.84% | 69,9 66,8 4.68% | 72,3 66,9 8.02% | 65,9 62,0 6.17% | -1 076 62,1 -1834.28% | 31,9 35,9 -11.13% | 30,4 34,9 -13.01% | 27,4 | 36,8 | 34,8 | 38,9 | 27,6 |
Net income Million USD | Released Forecast Spread | 41,4 | 38,8 44,1 -11.92% | 37,1 55,9 -33.61% | 50,3 48,1 4.55% | 48,9 47,8 2.16% | 45,7 44,5 2.73% | -1 062 44,2 -2502.3% | 15,3 23,5 -34.91% | -1,09 36,4 -102.99% | 27,9 | 31,5 | 28,9 | 33,5 | 22,1 |
EPS USD | Released Forecast Spread | 0,25 0,28 -11.4% | 0,21 0,30 -29.44% | 0,21 0,31 -32.67% | 0,28 0,31 -9.5% | 0,27 0,26 3.48% | 0,25 0,24 2.74% | -6,84 0,25 -2872.94% | 0,09 0,16 -42.86% | -0,01 0,16 -106.12% | 0,20 | 0,22 | 0,18 | 0,23 | 0,14 |
Announcement Date | 17/02/22 | 05/05/22 | 04/08/22 | 03/11/22 | 16/02/23 | 04/05/23 | 08/08/23 | 09/11/23 | 15/02/24 | - | - | - | - | - |
Past sector events for Ironwood Pharmaceuticals, Inc.
2024-04-17 | HINOVA PHARMACEUTICALS INC.: Q4 2023 Earnings Release |
2024-04-17 02:07 am | TELIX PHARMACEUTICALS LIMITED: March 2024 Sales and Revenue Release - Activities Report |
2024-04-10 04:10 pm | PHARVARIS N.V.: Q4 2023 Earnings Release |
2024-04-10 01:22 am | POLARIS GROUP: March 2024 Sales and Revenue Release |
2024-04-02 02:30 am | ABIVAX: Q4 2023 Earnings Release |
2024-04-01 09:00 am | BIOMEA FUSION, INC.: Q4 2023 Earnings Release |
2024-03-28 10:42 pm | ALPHAMAB ONCOLOGY: Q4 2023 Earnings Release |
2024-03-28 04:28 pm | CENTESSA PHARMACEUTICALS PLC: Q4 2023 Earnings Release |
2024-03-28 04:05 pm | ARRIVENT BIOPHARMA, INC.: Q4 2023 Earnings Release |
2024-03-28 07:10 am | HANGZHOU TIGERMED CONSULTING CO., LTD: Q4 2023 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- IRWD Stock
- Calendar Ironwood Pharmaceuticals, Inc.